What Has Been the Progress and Growth of the Needle-Free Drug Delivery Devices Market in Recent Years?
The needle-free drug delivery devices market has seen considerable growth due to a variety of factors.
• The needle-free drug delivery devices market has grown rapidly in recent years. It will expand from $16.7 billion in 2024 to $18.67 billion in 2025, at a CAGR of 11.8%.
The market growth is attributed to the increased prevalence of chronic diseases, demand for painless drug delivery, a rising geriatric population, and regulatory support for needle-free technologies.
What Can Be Expected from the Needle-Free Drug Delivery Devices Market Size?
The needle-free drug delivery devices market is expected to maintain its strong growth trajectory in upcoming years.
• The needle-free drug delivery devices market is expected to grow to $28.86 billion by 2029 at a CAGR of 11.5%.
The market is driven by the demand for painless medication administration, the rise of patient-centric healthcare, and advancements in technology. Key trends include the adoption of wearable devices, novel microfluidic technologies, pediatric-friendly solutions, and the integration of AI and machine learning in drug delivery systems.
What Are the Critical Driver Fuelling The Needle-Free Drug Delivery Devices Market's Growth?
The growing prevalence of diabetes is projected to drive the needle-free drug delivery device market. Diabetes is a chronic condition characterized by high blood sugar levels caused by insufficient insulin production or the body's poor use of insulin. Contributing factors include sedentary lifestyles, unhealthy diets, genetics, urbanization, aging populations, and limited healthcare access. Needle-free drug delivery devices, which include jet injectors and transdermal patches, offer a more comfortable alternative to traditional insulin injections. These devices eliminate the discomfort and anxiety associated with needles. For example, in June 2024, the NHS reported that over 549,000 additional individuals in England were identified at risk of developing type 2 diabetes, increasing the number of people with pre-diabetes to 3.6 million. This represents a nearly 20% rise compared to 2022, indicating the increasing prevalence of diabetes.
How Is The Needle-Free Drug Delivery Devices Market segmented?
The needle-free drug delivery devices market covered in this report is segmented –
1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices
Pre-Book The Needle-Free Drug Delivery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Needle-Free Drug Delivery Devices Market?
Key players in the needle-free drug delivery device market are concentrating their efforts on innovative products like dual chamber inhalers to improve efficiency and ease of use, catering to the changing requirements of healthcare providers and patients. These dual-chamber devices have two sections capable of holding separate medications, enabling multiple drugs to be combined within a single inhaler, enhancing treatment delivery and patient convenience. For example, in April 2024, Berry Global, a plastic manufacturing company from the USA, unveiled their product, the BerryHaler. This is an advanced dry powder inhaler (DPI) aimed at transforming patient-focused healthcare solutions. The BerryHaler, a dual-chamber inhaler with a dose counter, ensures exact dispensing of medication. Its all-plastic build, free from any metal components, makes it perfectly suitable for complex inhalation therapies. This design simplifies drug dosage and combination. Other sophisticated features consist of a bi-directional mouthpiece cover for ease and cleanliness and sound signals for correct usage. The built-in dose counter assists in accurate tracking of medication consumption, preventing dosage mishaps.
Who Are the Key Players In The Needle-Free Drug Delivery Devices Market?
Major companies operating in the needle-free drug delivery devices market are:
• Pfizer Inc.
• Merck & Co. Inc.
• Bayer AG
• 3M Company
• Medtronic plc
• Novo Nordisk AS
• Becton
• Dickinson and Company
• Endo International plc
• Insulet Corporation
• Purdue Pharma L.P.
• Antares Pharma Inc.
• MannKind Corporation
• Med-Jet Inc.
• Portal Instruments
• PharmaJet
• Inovio PharmaceuticalsInc.
• National Medical Products Inc.
• Mika Medical Co. Ltd.
• Medical International Technology Inc. (MTI)
• NanoPass Technologies Ltd.
• PenJet Corporation
• Akra Dermojet S.A.
• NuGen Medical Devices Inc.
• Crossject SA
• Injex Pharma AG
What Is The Most Dominant Region In The Needle-Free Drug Delivery Devices Market?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
